SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-021199
Filing Date
2017-11-02
Accepted
2017-11-02 16:11:13
Documents
47
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cala-10q_20170930.htm 10-Q 1616684
2 EX-10.1 SEVERANCE BENEFIT PLAN cala-ex101_64.htm EX-10.1 132561
3 EX-31.1 cala-ex311_6.htm EX-31.1 15730
4 EX-32.1 cala-ex321_7.htm EX-32.1 7510
  Complete submission text file 0001564590-17-021199.txt   5106426

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cala-20170930.xml EX-101.INS 1061705
6 XBRL TAXONOMY EXTENSION SCHEMA cala-20170930.xsd EX-101.SCH 35112
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cala-20170930_cal.xml EX-101.CAL 34476
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cala-20170930_def.xml EX-101.DEF 82450
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cala-20170930_lab.xml EX-101.LAB 263961
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cala-20170930_pre.xml EX-101.PRE 186557
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36644 | Film No.: 171172442
SIC: 2834 Pharmaceutical Preparations